Yale Medicine doctors: Clinical trials show Pfizer vaccine is 100% effective in ages 12-15
Doctors at Yale Medicine who worked on clinical trials of the Pfizer-BioNTech COVID-19 vaccine say it is shown to be 100% effective and safe for those between the ages of 12 and 15.
•
Mar 31, 2021, 6:57 PM
•
Updated 1,454 days ago
Share:
More Stories
Hometown Heroes in Connecticut
341ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
539ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
545ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
551ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
572ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
591ds agoHometown Heroes in Connecticut
341ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
539ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
545ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
551ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
572ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
591ds agoDoctors at Yale Medicine who worked on clinical trials of the Pfizer-BioNTech COVID-19 vaccine say it is shown to be 100% effective and safe for those between the ages of 12 and 15.
Dr. Onyema Ogbuagu, who is in charge of COVID-19 clinical studies at Yale Medicine, says that the Pfizer vaccine may be even more effective in young teens than it is in adults.
He says in thousands of patients between the ages of 12 and 16 who received the vaccine, none have contracted COVID-19. Side effects were also comparable to other age groups.
Ogbuagu says the antibody response in the teen group was even stronger than what the vaccine provoked in adults.
The FDA still has to expand Pfizer's emergency use authorization before the vaccine becomes widely available for young teens. Ogbuagu says that approval may come next month.
He says getting young people vaccinated as soon as possible can only make schools safer for in-person learning.
The Pfizer vaccine is in early clinical trials for children 11 and younger.
Researchers say 18 trial participants contracted COVID-19, but all of them had been given the placebo vaccine.
No participants showed a serious adverse reaction.
More from News 12
2:34
Guide: Safety tips to help prevent home burglaries
2:19
Guide: Safety measures to help prevent fires and how to escape one
2:07
Tips on how to avoid confrontation with sharks while swimming in the ocean
2:33
5 tips to prevent mosquito bites and getting sick from viruses
2:39
NEWS 12 EXCLUSIVE: ‘He drove into the water.’ Car drives off dock in Patchogue; News 12 crew helps in the rescue
0:44
